HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity - Wikidata - wikimedia - TriplyDB

HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity

HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity

http://www.wikidata.org/entity/Q35108680

about

Principles of antibody-mediated TNF receptor activation 4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques Enhanced anti-tumor therapeutic efficacy of DNA vaccine by fusing the E7 gene to BAFF in treating human papillomavirus-associated cancer.Recent progress in the development of white spot syndrome virus vaccines for protecting shrimp against viral infection.Therapeutic targeting of CD70 and CD27.Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells.Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection.The growing impact of lyophilized cell-free protein expression systems.Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections.Ex vivo nicotine stimulation augments the efficacy of human peripheral blood mononuclear cell-derived dendritic cell vaccination via activating Akt-S6 pathway.

P2860

Q26796270-0CE96A6E-3B42-4785-8DA5-39250180B993 Q27314155-33AAB5FC-A8CA-405B-8256-A6B7E95CB2B0 Q33779343-11DF0229-4C46-497F-A585-9CE973497F5B Q38667053-1CA1427E-FF28-4B89-A441-1B61A76DF7AA Q38749841-0F8BA93A-BC7C-46A5-AE62-92019A379D1C Q38771001-2CE800BD-D265-4C3F-BA89-093D86177AE7 Q40588780-A7C92572-E984-48D6-AFE6-88BE4952B857 Q42536890-F1B69A74-28EE-4331-AFA1-9DBA278FB5C2 Q50335281-39C0E32B-A2FF-41F2-A6E4-D5F312E1F957 Q53352240-5A504260-DACB-4FB1-AD5F-B40DAC5CD6B9

P2860

HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity

http://www.wikidata.org/entity/Q35108680

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

HIV-1 adenoviral vector vaccin ...... l mediated anti-viral immunity

@ast

HIV-1 adenoviral vector vaccin ...... l mediated anti-viral immunity

@en

type

label

HIV-1 adenoviral vector vaccin ...... l mediated anti-viral immunity

@ast

HIV-1 adenoviral vector vaccin ...... l mediated anti-viral immunity

@en

prefLabel

HIV-1 adenoviral vector vaccin ...... l mediated anti-viral immunity

@ast

HIV-1 adenoviral vector vaccin ...... l mediated anti-viral immunity

@en

P1433

Q35108680-8D5595FF-DC76-462D-AF99-17D068FECF03

P1476

Q35108680-B2D7DA8C-2AC7-4328-BF86-E010841FF613

P2093

Q35108680-02B86DAF-FD50-4B80-B2E3-5A1B2008A748

Q35108680-2DEC6FD9-8DED-476B-979E-4D94690CA0DF

Q35108680-82115EAE-0C8C-464C-9DDB-6EC8343D5151

Q35108680-961073AE-B84C-40C3-BF6A-39F25FE96000

Q35108680-9EE73D5B-2DC3-4389-8E8A-C0BF8C169271

Q35108680-CD21ADD8-B258-41F3-BBA6-5BEACA25DA2F

Q35108680-DA42B20D-434E-4123-8F5E-90E385CE670C

Q35108680-E98D0200-6DAB-4CB1-A13B-ACCAB6E629EE

P2860

Q35108680-14F9BB65-D22E-41DB-A611-B95726C99B57

Q35108680-15A70AE8-2DCC-48D7-B2B8-504FC9CBD80B

Q35108680-1A9BDB8E-FA98-449D-9663-426E10B232FC

Q35108680-1B910475-FB7E-45D8-88A5-9F02DB588F05

Q35108680-21EE336F-987B-47C5-A792-2403E664B1A8

Q35108680-2856CA8C-F577-4352-87D1-17797D29A0BE

Q35108680-36E7B5DE-10A9-4B3F-B694-C773F7116E06

Q35108680-38B09F9A-8C85-4C34-8B65-EDB94C8E08D0

Q35108680-3A17EF4A-6A66-4D7A-A78B-8C9A36C5AFE6

Q35108680-3AE4C416-7AB6-4768-BD90-C87F95F8CFF6

P304

Q35108680-E5F64556-66F0-4CFA-992E-9B252AC87B7A

P31

Q35108680-0DAAA193-2489-445E-BE98-43772BE72977

P356

Q35108680-545CC969-4D72-4174-9C29-E9164BECA063

P407

Q35108680-CE290694-B826-409D-B613-88F68CFF3DF9

P433

Q35108680-766CE023-52A8-4CB4-A39E-6885E3EF7AA3

P478

Q35108680-169A1CB0-0324-4F1E-9EC8-AF1F1E279354

P50

Q35108680-A8C55BD2-62CE-436B-B8C4-DB1D0D9730B5

P577

Q35108680-1DADCE69-F832-40DA-9F83-54CB39F2BC79

P5875

Q35108680-98B971DE-826F-4A3C-B234-4DD552ACBCEB

P698

Q35108680-C68B2575-B1CC-44E6-A4BF-6969CAF5672E

P921

Q35108680-9652663C-CD62-45F9-AA5A-0190B9903D69

P932

Q35108680-78C8422A-1C49-4766-827C-969DC2B2A9E0

P356

JOURNAL.PONE.0090100

P1433

P1476

HIV-1 adenoviral vector vaccin ...... l mediated anti-viral immunity

@en

P2093

Francesca N Raffa

http://www.w3.org/2001/XMLSchema#string

Geoffrey W Stone

http://www.w3.org/2001/XMLSchema#string

James M Termini

http://www.w3.org/2001/XMLSchema#string

Katherine A Fuller

http://www.w3.org/2001/XMLSchema#string

Sachin Gupta

http://www.w3.org/2001/XMLSchema#string

Sakhi Philip

http://www.w3.org/2001/XMLSchema#string

Saravana Kanagavelu

http://www.w3.org/2001/XMLSchema#string

Yaelis Rivas

http://www.w3.org/2001/XMLSchema#string

P2860

Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity

A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis

Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.

Molecular structure of pulmonary surfactant protein D (SP-D)

The role of the BAFF/APRIL system on T cell function

BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses

B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells

Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccination

P304

e90100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0090100

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Richard S Kornbluth

P577

2014-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260447712

http://www.w3.org/2001/XMLSchema#string

P698

24587225

http://www.w3.org/2001/XMLSchema#string

P921

P932

3938597

http://www.w3.org/2001/XMLSchema#string